Global Laparoscopic Gynecological Procedures Market Size, Share and Trends, 2026-2033 | Robotic-Assisted Surgery and AI Training Unlock Growth to USD 26.1 Billion
Capitalize on minimally invasive demand through robotic-assisted surgery, AI-powered training and disease-specific toolkits, while targeting underserved regions and expanding surgeon access.
Dublin, Nov. 16, 2026 (GLOBE NEWSWIRE) -- "Laparoscopic Gynecological Procedures Market Size, Share & Trends Analysis Report 2026-2033" has been added to ResearchAndMarkets.com's offering.
The global laparoscopic gynecological procedures market was valued at USD 20.5 billion in 2025 and is expected to increase from USD 21.2 billion in 2026 to USD 26.1 billion by 2033. The market is projected to expand at a CAGR of 3.1% from 2026 to 2033. North America led the industry in 2025, accounting for 50.2% of global revenue.
Market growth is being supported by the increasing adoption of minimally invasive gynecological surgery, greater patient preference for shorter recovery periods and reduced scarring, and the rising prevalence of endometriosis, uterine fibroids, ovarian cysts, and other gynecological disorders. Technological advances in laparoscopic instruments, energy devices, visualization systems, and robotic-assisted surgery are also improving procedural accuracy and expanding access to complex pelvic interventions.
Robotic-Assisted Surgery Advances
Surgical robots are accelerating innovation by enhancing precision, reproducibility, and surgeon access during complex gynecological procedures. Platforms such as da Vinci and Senhance incorporate wristed instruments, high-definition 3D visualization, and motion scaling to support procedures including endometriosis excision and laparoscopic myomectomy.
A study published by Intuitive Surgical in April 2025 indicated that robotic-assisted surgery can improve access to minimally invasive care, particularly in underserved medical areas affected by limited specialist training and hospital infrastructure. Hospitals adopting robotic-assisted surgery reported higher utilization of minimally invasive procedures across diverse patient populations. The integration of real-time analytics, AI-assisted image guidance, and digital feedback is also strengthening surgical planning and intraoperative decision-making. Standardized robotic workflows may further support surgeon training, credentialing, and consistent procedural delivery across varying experience levels.
Training and Technology Integration
Demand for advanced laparoscopic gynecological procedures is increasing alongside participation in laparoscopic fellowships and simulation-based education. Training frequently focuses on total laparoscopic hysterectomy (TLH), laparoscopic supracervical hysterectomy (LSH), laparoscopic ovarian cystectomy, and other technically demanding procedures.
In November 2023, Ethicon, a Johnson & Johnson MedTech company, introduced an AI-powered laparoscopic skills training platform at the American Association of Gynecological Laparoscopists (AAGL) Global Congress. The platform provides real-time feedback, objective performance metrics, personalized guidance, and repeated practice in a simulated environment. Such education initiatives are helping healthcare providers strengthen surgical capabilities and increase the adoption of minimally invasive gynecological surgery.
Rising Burden of Gynecological Disorders
The growing incidence of endometriosis and uterine fibroids is creating sustained demand for laparoscopic diagnosis and treatment. The World Health Organization estimates that endometriosis affects approximately 190 million reproductive-age individuals worldwide, representing around 10% of that population.
Research published in Springer Nature in May 2023 found that the global incidence of uterine fibroids increased by 67% between 1990 and 2019, while prevalence rose by 79% and years lived with disability increased by 77%. The burden was particularly pronounced in low- and middle-Socio-demographic Index regions, with peak incidence among individuals aged 35-44.
Earlier detection, stronger awareness, and improved access to gynecological care are expanding the number of patients eligible for laparoscopic intervention. In response, healthcare facilities are investing in surgical systems, specialized instruments, and clinical training. Manufacturers are also introducing disease-specific solutions, including fibroid morcellators and endometriosis resection kits, to improve procedural efficiency.
Report Segmentation
The report provides revenue forecasts and industry trend analysis at global, regional, and country levels for 2021 - 2033. Market segmentation covers procedure, end-use, and region.
Procedure Outlook
- Laparoscopic Hysterectomy
- Laparoscopic Adnexal
- Laparoscopic Endometrial Excision
- Laparoscopic Diagnostic Procedures
- Laparoscopic Myomectomy
- Laparoscopic Colpopexy
End-use Outlook
- Hospitals
- Ambulatory Surgery Centers
- Clinics
Regional Outlook
- North America: U.S., Canada, and Mexico
- Europe: UK, Germany, France, Italy, Spain, Denmark, Sweden, and Norway
- Asia Pacific: Japan, China, India, Australia, Thailand, and South Korea
- Latin America: Brazil and Argentina
- Middle East and Africa: South Africa, Saudi Arabia, UAE, and Kuwait
Strategic Value of the Report
- Detailed analysis of major market segments and geographic opportunities
- Assessment of the competitive landscape and key market participants
- Revenue forecasts to support market planning and investment decisions
- Analysis of emerging technologies, growth drivers, and industry trends
- Actionable insights for identifying revenue opportunities and developing competitive strategies
- Coverage of product innovation, regional performance, and market share dynamics
Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Procedure
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. The internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Procedure outlook
2.2.2. End use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Laparoscopic Gynecological Procedures Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Laparoscopic Gynecological Procedures Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Laparoscopic Gynecological Procedures Market: Procedure Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Laparoscopic Gynecological Procedures Procedure Market Movement Analysis
4.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, Procedure, 2021 to 2033 (USD Million)
4.4. Laparoscopic Hysterectomy
4.4.1. Laparoscopic Hysterectomy market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Laparoscopic Adnexal
4.5.1. Laparoscopic Adnexal market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Laparoscopic Endometrial Excision
4.6.1. Laparoscopic Endometrial Excision market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Laparoscopic Diagnostic Procedures
4.7.1. Laparoscopic Diagnostic Procedures market estimates and forecasts 2021 to 2033 (USD Million)
4.8. Laparoscopic Myomectomy
4.8.1. Laparoscopic Myomectomy market estimates and forecasts 2021 to 2033 (USD Million)
4.9. Laparoscopic Colpopexy
4.9.1. Laparoscopic Colpopexy market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Laparoscopic Gynecological Procedures Market: End Use Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Laparoscopic Gynecological Procedures End Use Market Movement Analysis
5.3. Global Laparoscopic Gynecological Procedures Market Size & Trend Analysis, End Use, 2021 to 2033 (USD Million)
5.4. Hospitals
5.4.1. Hospitals' market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Clinics
5.5.1. Clinics market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Ambulatory Surgery Centers
5.6.1. Ambulatory Surgery Centers market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Laparoscopic Gynecological Procedures Market: Regional Estimates & Trend Analysis by Procedure, End Use
6.1. Regional Market Share Analysis, 2026 & 2033
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033
6.5. Country Analysis Framework
6.5.1. Key country dynamics
6.5.2. Competitive scenario
6.5.3. Regulatory framework
6.5.4. Reimbursement structure
6.6. North America
6.6.1. U.S.
6.6.1.1. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
6.6.2. Canada
6.6.2.1. Canada market estimates and forecasts 2021 to 2033 (USD Million)
6.6.3. Mexico
6.6.3.1. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Europe
6.7.1. UK
6.7.1.1. UK market estimates and forecasts 2021 to 2033 (USD Million)
6.7.2. Germany
6.7.2.1. Germany market estimates and forecasts 2021 to 2033 (USD Million)
6.7.3. France
6.7.3.1. France market estimates and forecasts 2021 to 2033 (USD Million)
6.7.4. Italy
6.7.4.1. Italy market estimates and forecasts 2021 to 2033 (USD Million)
6.7.5. Spain
6.7.5.1. Spain market estimates and forecasts 2021 to 2033 (USD Million)
6.7.6. Norway
6.7.6.1. Norway market estimates and forecasts 2021 to 2033 (USD Million)
6.7.7. Sweden
6.7.7.1. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
6.7.8. Denmark
6.7.8.1. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Japan market estimates and forecasts 2021 to 2033 (USD Million)
6.8.2. China
6.8.2.1. China market estimates and forecasts 2021 to 2033 (USD Million)
6.8.3. India
6.8.3.1. India market estimates and forecasts 2021 to 2033 (USD Million)
6.8.4. Australia
6.8.4.1. Australia market estimates and forecasts 2021 to 2033 (USD Million)
6.8.5. South Korea
6.8.5.1. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
6.8.6. Thailand
6.8.6.1. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
6.9.2. Argentina
6.9.2.1. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
6.10. MEA
6.10.1. South Africa
6.10.1.1. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
6.10.2. Saudi Arabia
6.10.2.1. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
6.10.3. UAE
6.10.3.1. UAE market estimates and forecasts 2021 to 2033 (USD Million)
6.10.4. Kuwait
6.10.4.1. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, Key Market Participants
7.2. Company/Competition Categorization
7.3. Key company market share analysis, 2026
7.4. Company Position Analysis
7.5. Company Categorization (Emerging Players, Innovators, and Leaders)
7.6. Company Profiles
7.6.1. Medtronic
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Product benchmarking
7.6.1.4. Strategic initiatives
7.6.2. Stryker
7.6.2.1. Company overview
7.6.2.2. Financial performance
7.6.2.3. Product benchmarking
7.6.2.4. Strategic initiatives
7.6.3. Karl Storz SE & CO. Kg
7.6.3.1. Company overview
7.6.3.2. Financial performance
7.6.3.3. Product benchmarking
7.6.3.4. Strategic initiatives
7.6.4. Johnson and Johnson
7.6.4.1. Company overview
7.6.4.2. Financial performance
7.6.4.3. Product benchmarking
7.6.4.4. Strategic initiatives
7.6.5. Olympus Corporation
7.6.5.1. Company overview
7.6.5.2. Financial performance
7.6.5.3. Product benchmarking
7.6.5.4. Strategic initiatives
7.6.6. CONMED Corporation
7.6.6.1. Company overview
7.6.6.2. Financial performance
7.6.6.3. Product benchmarking
7.6.6.4. Strategic initiatives
7.6.7. B. Braun SE
7.6.7.1. Company overview
7.6.7.2. Financial performance
7.6.7.3. Product benchmarking
7.6.7.4. Strategic initiatives
7.6.8. CooperCompanies
7.6.8.1. Company overview
7.6.8.2. Financial performance
7.6.8.3. Product benchmarking
7.6.8.4. Strategic initiatives
7.6.9. Richard Wolf GmbH
7.6.9.1. Company overview
7.6.9.2. Financial performance
7.6.9.3. Product benchmarking
7.6.9.4. Strategic initiatives
7.6.10. Microline Surgical
7.6.10.1. Company overview
7.6.10.2. Financial performance
7.6.10.3. Product benchmarking
7.6.10.4. Strategic initiatives
7.6.11. Welfare Medical Ltd.
7.6.11.1. Company overview
7.6.11.2. Financial performance
7.6.11.3. Product benchmarking
7.6.11.4. Strategic initiatives
7.6.12. Intuitive Surgical
7.6.12.1. Company overview
7.6.12.2. Financial performance
7.6.12.3. Product benchmarking
7.6.12.4. Strategic initiatives
7.6.13. Shenzhen Mindray Bio Medical Electronics Co., Ltd.
7.6.13.1. Company overview
7.6.13.2. Financial performance
7.6.13.3. Product benchmarking
7.6.13.4. Strategic initiatives
List of Tables [60]
List of Figures [93]
Companies Featured
- Medtronic
- Stryker
- Karl Storz SE & CO. Kg
- Johnson and Johnson
- Olympus Corporation
- CONMED Corporation
- B. Braun SE
- CooperCompanies
- Richard Wolf GmbH
- Microline Surgical
- Welfare Medical Ltd.
- Intuitive Surgical
- Shenzhen Mindray Bio Medical Electronics Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/m5dzm8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

